Panmure Gordon reiterated their hold rating on shares of Ekf Diagnostics Holding PLC (LON:EKF) in a research report sent to investors on Wednesday.

Separately, N+1 Singer reiterated a corporate rating on shares of Ekf Diagnostics Holding PLC in a research note on Thursday, July 6th.

Ekf Diagnostics Holding PLC (LON:EKF) opened at 25.50 on Wednesday. Ekf Diagnostics Holding PLC has a 52-week low of GBX 14.00 and a 52-week high of GBX 26.50. The firm’s market cap is GBX 118.39 million. The stock has a 50 day moving average price of GBX 24.55 and a 200 day moving average price of GBX 21.96.

ILLEGAL ACTIVITY NOTICE: “Ekf Diagnostics Holding PLC’s (EKF) “Hold” Rating Reiterated at Panmure Gordon” was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this story on another publication, it was illegally stolen and reposted in violation of international copyright and trademark law. The correct version of this story can be viewed at https://www.thecerbatgem.com/2017/09/09/ekf-diagnostics-holding-plcs-ekf-hold-rating-reiterated-at-panmure-gordon.html.

About Ekf Diagnostics Holding PLC

EKF Diagnostics Holdings plc is engaged in developing, manufacturing and supplying of products and services into the in-vitro diagnostic (IVD) market place. The Company manufactures and sells diagnostic instruments, reagents and certain ancillary products. The Company’s point-of-care range includes hemoglobin analyzers, HbA1c analyzers and glucose analyzers for use in the screening, monitoring and diagnosis of patients, as well as rapid tests for pregnancy and common infectious diseases.

Receive News & Stock Ratings for Ekf Diagnostics Holding PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ekf Diagnostics Holding PLC and related stocks with our FREE daily email newsletter.